We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
-29.4%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$853M
AUM Growth
-$21.7M
Cap. Flow
+$306M
Cap. Flow %
35.89%
Top 10 Hldgs %
46.26%
Holding
212
New
44
Increased
26
Reduced
27
Closed
63

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 18.63%
2 Healthcare 17.83%
3 Communication Services 10.12%
4 Financials 8%
5 Materials 5.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
B
26
Barrick Mining
B
$68.4B
$9.37M 1.1%
+511,477
New +$9.59M
BRK.B icon
27
PUT
Berkshire Hathaway Class B
BRK.B
$1.11T
$9.14M 1.07%
+50,000
New +$10.6M
KO icon
28
PUT
Coca-Cola
KO
$374B
$8.85M 1.04%
200,000
-100,000
-33% -$5.4M
DSSI
29
DELISTED
Diamond S Shipping Inc. Common Shares
DSSI
$8.47M 0.99%
717,653
+32,808
+5% +$384K
DHT icon
30
DHT Holdings
DHT
$2.89B
$7.67M 0.9%
1,000,010
+485,010
+94% +$3.07M
KG
31
Kestrel Group
KG
$71.1M
$7.17M 0.84%
393,848
SBUX icon
32
Starbucks
SBUX
$121B
$6.58M 0.77%
+100,000
New +$8.09M
JNJ icon
33
PUT
Johnson & Johnson
JNJ
$623B
$6.56M 0.77%
+50,000
New +$7.09M
VTR icon
34
Ventas
VTR
$47.3B
$6.03M 0.71%
+225,000
New +$11.2M
DRTT
35
DELISTED
DIRTT Environmental Solutions Ltd. Common Shares
DRTT
$5.98M 0.7%
+5,904,800
New +$13.5M
ADMA icon
36
ADMA Biologics
ADMA
$2.13B
$5.76M 0.68%
2,000,000
+1,300,000
+186% +$4.49M
FENC icon
37
Fennec Pharmaceuticals
FENC
$370M
$5.64M 0.66%
950,000
MGTX icon
38
MeiraGTx Holdings
MGTX
$1.16B
$5.59M 0.66%
415,874
+10,874
+3% +$184K
YARW
39
Yarrow Bioscience, Inc. Common Stock
YARW
$25.5M
$5.35M 0.63%
+555
New +$8.7M
ONDK
40
DELISTED
On Deck Capital, Inc.
ONDK
$5.33M 0.62%
3,459,669
+598,949
+21% +$1.95M
WFC icon
41
Wells Fargo
WFC
$270B
$5.17M 0.61%
+180,000
New +$7.65M
FATE icon
42
Fate Therapeutics
FATE
$308M
$5M 0.59%
225,000
CARG icon
43
CarGurus
CARG
$3.28B
$4.81M 0.56%
+254,000
New +$7.27M
GSAT icon
44
Globalstar
GSAT
$10.7B
$4.54M 0.53%
1,027,719
CUE icon
45
Cue Biopharma
CUE
$114M
$4.54M 0.53%
10,667
CMPR icon
46
Cimpress
CMPR
$2.5B
$4.52M 0.53%
+84,997
New +$8.62M
PCG icon
47
PUT
PG&E
PCG
$38B
$4.5M 0.53%
+500,000
New +$6.64M
VTR icon
48
CALL
Ventas
VTR
$47.3B
$4.02M 0.47%
+150,000
New +$7.45M
TGTX icon
49
TG Therapeutics
TGTX
$7.56B
$3.92M 0.46%
398,271
ERII icon
50
Energy Recovery
ERII
$462M
$3.87M 0.45%
520,000
-20,000
-4% -$190K

Similar funds

683 Capital Management's Q1 2020 Portfolio in Review

As of Q1 2020, 683 Capital Management held 212 positions worth $853M, down 2.5% from $874M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

683 Capital Management deployed $306M of net new capital in Q1 2020, opening 44 new positions and adding to 26 existing holdings. Its largest new stake was Just Eat Takeaway.com N.V. American Depositary Shares: 307,911 shares worth $25.1M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, down from 22% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Alnylam Pharmaceuticals, an estimated $6.35M trimmed.

  • 683 Capital Management's largest Q1 2020 buy was Just Eat Takeaway.com N.V. American Depositary Shares: 307,911 shares worth $25.1M.
  • 683 Capital Management added most to Capital One in Q1 2020, an estimated $47.5M increase.
  • 683 Capital Management's biggest Q1 2020 reduction was Alnylam Pharmaceuticals, cutting an estimated $6.35M.
  • 683 Capital Management fully exited Redhill Biopharma in Q1 2020, selling an estimated $6.28M.
  • 683 Capital Management's ten largest holdings make up 46% of its $853M portfolio in Q1 2020.
  • 683 Capital Management opened 44 new positions and closed 63 in Q1 2020.
  • 683 Capital Management's portfolio value fell 2.5% quarter-over-quarter to $853M.

Based on 683 Capital Management's 13F filing for Q1 2020, filed 15 May 2020.